We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIOS market cap is 1.58M. The company's latest EPS is EUR -0.1764 and P/E is -0.06.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.32M | 4.21M | 312k | 316k | 545k |
| Operating Income | -11.17M | -17.39M | -877k | -2.31M | -21.45M |
| Net Income | -10.46M | -11.94M | -984k | -2.04M | -28.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 22.39M | 24.84M | 1.16M | 29.32M | 9.56M |
| Total Liabilities | 20.35M | 21.51M | 3.83M | 26.2M | 32.26M |
| Total Equity | 2.05M | 3.33M | -2.67M | 3.12M | -22.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -10.4M | -16.08M | -1.07M | -1.91M | -3.47M |
| Investing | -302k | 11.91M | N/A | 1.95M | 6k |
| Financing | 11.16M | 10.19M | 1.17M | 1.05M | 1.74M |
| Market Cap | 1.58M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 3.03 |
| Price to Cash Ratio | 14.29 |
| Price to Book Ratio | -0.07 |
| Dividend Yield | - |
| Shares Outstanding | 163.18M |
| Average Volume (1 week) | 4.81M |
| Average Volume (1 Month) | 2.33M |
| 52 Week Change | -85.44% |
| 52 Week High | 0.189 |
| 52 Week Low | 0.008 |
| Spread (Intraday) | 0 (2.02%) |
| Company Name | Biosenic |
| Address |
rue granbonpre 11 , batiment h (bte 24) mont-saint-guibert, walloon brabant 1435 |
| Website | https://www.bonetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
